Biomarker in Clinical Studies

Date/Time: Wednesday, October 7, 2020 - 12:30 PM – 1:45 PM
Track: Interactive Workshop
Log in to Add to My Schedule


One of key reasons for the failed clinical trials is often due to inadequate biomarkers used for outcome measurements. There have been increasing NIH-funding mechanisms toward disease biomarker studies. This session will group a team of experts who are experienced in this area and share their insights in the establishment of biomarkers in clinical studies.


  • To reiterate the definition of biomarker and outcome measurements in clinical studies.

  • To discuss how to identify and validate biomarkers.

  • To discuss specific success or failure examples in biomarker studies.


Biomarkers in ALS Trials

Informative Predictive and Prognostic Biomarkers for Neuromuscular Clinical Trials

Statistical Issues in Biomarker Research